menu
    • menu

    Company profile for hVIVO

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    hVIVO was established in 1989 as a spin out from Queen Mary University, London, and is a clinical development services business pioneering human disease models based upon viral challenge. Using human challenge studies to establish early proof-of-concept, hVIVO's clinical trial platform can accelerate drug and vaccine development in respiratory and infectious diseases, hVIVO has leveraged its insights in established human disea...
    hVIVO was established in 1989 as a spin out from Queen Mary University, London, and is a clinical development services business pioneering human disease models based upon viral challenge. Using human challenge studies to establish early proof-of-concept, hVIVO's clinical trial platform can accelerate drug and vaccine development in respiratory and infectious diseases, hVIVO has leveraged its insights in established human disease challenge models in influenza (“Flu”), respiratory syncytial virus (“RSV”) and human rhinovirus (“HRV”) to expand the use of viral challenge in additional respiratory indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    hVIVOunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    10-12 Alie Street, 2nd Floor, London, England E1 8DE
    Telephone
    Telephone
    +44 (0) 20 7756 1300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hvivo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hvivo?
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hVIVO_UK

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ILiAD and hVIVO Sign LOI for BPZE1 Phase 3 Pertussis Vaccine Trial
    ILiAD and hVIVO Sign LOI for BPZE1 Phase 3 Pertussis Vaccine Trial

    27 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250127208008/en

    BUSINESSWIRE
    27 Jan 2025
    Share Share
    CRO hVIVO reels in £16.8M clinical trial deal for RSV drug
    CRO hVIVO reels in £16.8M clinical trial deal for RSV drug

    13 Dec 2023

    // Joseph Keenan FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/uk-cro-hvivo-reels-ps168m-clinical-trial-deal-rsv-drug

    Joseph Keenan FIERCE BIOTECH
    13 Dec 2023
    Share Share
    hVIVO raises 2023 revenue view on demand for respiratory therapy testings
    hVIVO raises 2023 revenue view on demand for respiratory therapy testings

    12 Sep 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/hvivo-raises-2023-revenue-forecast-strong-demand-respiratory-therapies-2023-09-12/

    REUTERS
    12 Sep 2023
    Share Share
    CRO hVIVO inks deal to test RSV drug in human challenge trial
    CRO hVIVO inks deal to test RSV drug in human challenge trial

    08 Feb 2023

    // Joseph Keenan FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/hvivo-inks-82m-deal-test-rsv-drug-human-challenge-trial

    Joseph Keenan FIERCE BIOTECH
    08 Feb 2023
    Share Share
    Open Orphan signs £10.4 million contract with global pharma client
    Open Orphan signs £10.4 million contract with global pharma client

    23 Aug 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/735248/open-orphan-signs-104-million-contract-global-pharma-client

    PHARMAFILE
    23 Aug 2022
    Share Share
    Open Orphan to commence influenza human challenge study
    Open Orphan to commence influenza human challenge study

    05 Aug 2022

    // John Pinching PHARMA TIMES

    https://www.pharmatimes.com/news/open_orphan_to_commence_influenza_human_challenge_study_1453010

    John Pinching PHARMA TIMES
    05 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Contact hVIVO and get a quotation

    hVIVO is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of HUMAN RHINOVIRUS STRAIN 16 (HRV-16) DRUG SUBSTANCE bulk offered by hVIVO

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search